{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:20:34Z","timestamp":1775280034904,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The impact of opioid use in lung transplant candidates on posttransplant outcomes is unknown. Studies on opioid therapy in kidney and liver transplant candidates have suggested increased risk of graft failure or death. We sought to analyze the relationship between pretransplant opioid use in lung transplant candidates and retransplant-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We retrospectively reviewed adult patients transplanted consecutively between November 2004 and August 2015. The exposure was any opioid use at time of transplant listing and primary outcome was retransplant-free survival, analyzed via Cox regression model adjusted for recipient age, gender, ethnicity, diagnosis, and bridging status. Secondary outcomes included duration of ventilation, intensive care unit and hospital length of stay, 3-month and 1-year survival, continuing opioid use at 1 year, and time to onset of chronic lung allograft dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The prevalence of opioid use at time of listing was 14% (61\/425). Median daily oral morphine equivalent dose was 31 mg (18\u201354). Recipient ethnicity was associated with pretransplant opioid use. Opioid use at time of listing did not increase risk of death or retransplantation in an adjusted model (hazard ratio 1.12 [95% confidence interval 0.65-1.83], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.6570). Secondary outcomes were similar between groups except hospital length of stay (opioid users 35 versus nonusers 27 d, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.014). Continued opioid use at 1-year posttransplant was common (27\/56, 48%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Pretransplant opioid use was not associated with retransplant-free survival in our cohort and should not necessarily preclude listing. Further work stratifying opioid use by indication and the association with opioid use disorder would be worthwhile.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003050","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:41:25Z","timestamp":1574664085000},"page":"1720-1725","source":"Crossref","is-referenced-by-count":17,"title":["Pretransplant Opioid Use and Survival After Lung Transplantation"],"prefix":"10.1097","volume":"104","author":[{"given":"Sana","family":"Vahidy","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alim","family":"Hirji","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kapasi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Weinkauf","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce","family":"Laing","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Lien","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran","family":"Halloran","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2013an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ki.2013.136","article-title":"A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk.","volume":"84","author":"Barrantes","year":"2013","journal-title":"Kidney Int"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000000248","article-title":"Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.","volume":"99","author":"Lentine","year":"2015","journal-title":"Transplantation"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/TP.0000000000002057","article-title":"Opioid prescription, morbidity, and mortality in US transplant recipients.","volume":"102","author":"Abbott","year":"2018","journal-title":"Transplantation"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/lt.24714","article-title":"Survival implications of opioid use before and after liver transplantation.","volume":"23","author":"Randall","year":"2017","journal-title":"Liver Transpl"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jamcollsurg.2017.12.025","article-title":"Association of pretransplantion opioid use with graft loss or death in liver transplantation patients with model of end-stage liver disease exceptions.","volume":"226","author":"Fleming","year":"2018","journal-title":"J Am Coll Surg"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1602529","DOI":"10.1183\/13993003.02529-2016","article-title":"Incident opioid use is associated with risk of respiratory harm in non-palliative COPD.","volume":"49","author":"Vozoris","year":"2017","journal-title":"Eur Respir J"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00228-017-2278-3","article-title":"Adverse cardiac events associated with incident opioid drug use among older adults with COPD.","volume":"73","author":"Vozoris","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 3","key":"R9-20231002","article-title":"Opioid and benzodiazepine use in lung transplant candidates: a national survey of policies and practices [abstract].","volume":"19","author":"Bruschwein","year":"2019","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMp1515917","article-title":"Reducing the risks of relief\u2013the CDC opioid-prescribing guideline.","volume":"374","author":"Frieden","year":"2016","journal-title":"N Engl J Med"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0269216314566839","article-title":"Outcomes of lung transplant candidates referred for co-management by palliative care: a retrospective case series.","volume":"29","author":"Colman","year":"2015","journal-title":"Palliat Med"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1378\/chest.12-0830","article-title":"Barriers to optimal palliative care of lung transplant candidates.","volume":"143","author":"Colman","year":"2013","journal-title":"Chest"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","article-title":"Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.","volume":"18","author":"Marciniuk","year":"2011","journal-title":"Can Respir J"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary.","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMra1800222","article-title":"Opioid tolerance in critical illness.","volume":"380","author":"Martyn","year":"2019","journal-title":"N Engl J Med"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/crj.12948","article-title":"Chronic opioid use and clinical outcomes in lung transplant recipients: a single-center cohort study.","volume":"12","author":"Drees","year":"2018","journal-title":"Clin Respir J"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R20-20231002","first-page":"81","article-title":"Medication compliance in patients with chronic pain.","volume":"17","author":"Kipping","year":"2014","journal-title":"Pain Physician"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ebnurs-2011-100106","article-title":"Concerns about medication and medication adherence in patients with chronic pain recruited from general practice.","volume":"15","author":"Broekmans","year":"2012","journal-title":"Evid Based Nurs"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pme.12035","article-title":"Adherence to pharmacological treatment of chronic nonmalignant pain in individuals aged 65 and older.","volume":"14","author":"Markotic","year":"2013","journal-title":"Pain Med"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mtc.2002.120342","article-title":"An economic evaluation of lung transplantation.","volume":"123","author":"Anyanwu","year":"2002","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:24:50Z","timestamp":1696224290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003050","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}